EPIX ESSA Pharma Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

EPIX [NASD]

ESSA Pharma Inc.

Healthcare | Biotechnology | Canada

statements

Index	-	P/E	-	EPS (ttm)	-1.17	Insider Own	4.91%	Shs Outstand	20.82M	Perf Week	-1.15%
Market Cap	107.46M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	8.61M	Perf Month	14.68%
Income	-	PEG	-	EPS next Q	-	Inst Own	66.95%	Short Float	0.32%	Perf Quarter	7.05%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	1.08	Perf Half Y	3.40%
Book/sh	1.93	P/B	2.67	EPS next Y	-	ROA	-	Target Price	-	Perf Year	112.35%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	1.41 - 6.14	Perf YTD	-6.18%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-15.92%	Beta	-
Dividend %	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	265.96%	ATR	0.22
Employees	-	Current Ratio	-	Sales Q/Q	-	Oper. Margin	-	RSI (14)	65.43	Volatility	2.84% 4.48%
Optionable	No	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	1.18	Prev Close	5.23
Shortable	Yes	LT Debt/Eq	-	Earnings	May 22 AMC	Payout	-	Avg Volume	25.88K	Price	5.16
Recom	-	SMA20	5.47%	SMA50	17.55%	SMA200	16.42%	Volume	30,628	Change	-1.34%

Oct-25-19

Initiated

Oppenheimer

Outperform

Jun-04-20 06:25PM	Hedge Funds Are Souring On ESSA Pharma Inc. (EPIX) Insider Monkey
May-27-20 07:00AM	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference CNW Group
05:32AM	EPIX: Additional Preclinical Data Presented at AUA 2020 Zacks Small Cap Research
May-18-20 08:13AM	ESSA Pharma Inc. (CVE:EPI): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
May-15-20 07:30AM	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting CNW Group
May-12-20 07:25AM	EPIX: FDA Gives OK to Initiate Phase 1 Trial of EPI-7386 Zacks Small Cap Research
May-07-20 05:05PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 PR Newswire
05:05PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 CNW Group
May-01-20 07:54AM	The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO Benzinga
Apr-30-20 05:45PM	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer PR Newswire
05:45PM	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer CNW Group
Apr-13-20 06:08PM	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement PR Newswire
Apr-02-20 05:45AM	EPIX: EPI-7386 IND Filed Zacks Small Cap Research
Mar-31-20 07:00AM	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update PR Newswire
07:00AM	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update CNW Group
Mar-24-20 04:00PM	Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies ACCESSWIRE +5.27%
Mar-19-20 09:18AM	ESSA Pharma (CVE:EPI) Is In A Good Position To Deliver On Growth Plans Simply Wall St. +8.36%
Feb-27-20 07:51PM	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
Feb-18-20 06:10AM	EPIX: IND Filing for EPI-7386 in 1Q20 Zacks Small Cap Research
Feb-13-20 05:48PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019 PR Newswire
05:48PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019 CNW Group
Feb-10-20 06:15PM	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia CNW Group
Dec-30-19 06:15AM	EPIX: Phase 1 Clinical Trial for EPI-7386 to Initiate in 1Q20 Zacks Small Cap Research
Dec-22-19 06:41PM	Hedge Funds Have Never Been This Bullish On ESSA Pharma Inc. (EPIX) Insider Monkey
Dec-19-19 05:15PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019 PR Newswire
Dec-12-19 11:35AM	Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors GlobeNewswire
Dec-03-19 11:00AM	How Many ESSA Pharma Inc. (CVE:EPI) Shares Did Insiders Buy, In The Last Year? Simply Wall St. -9.92%
Nov-11-19 09:00AM	Encode Ideas, L.P. Announces the Initiation of Research Coverage on ESSA Pharma, Inc. Newsfile
Oct-30-19 06:00AM	ESSA Pharma Grants Stock Options PR Newswire
06:00AM	ESSA Pharma Grants Stock Options CNW Group
Oct-28-19 07:30AM	ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics CNW Group +5.75%
Oct-18-19 04:15PM	ESSA Announces Changes to its Board of Directors PR Newswire +8.23%
04:15PM	ESSA Announces Changes to its Board of Directors CNW Group
Oct-11-19 08:15AM	EPIX: New Preclinical Data for EPI-7386 Presented at ESMO 2019 Zacks Small Cap Research +6.20%
Oct-07-19 02:04PM	ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants PR Newswire
02:04PM	ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants CNW Group
Sep-28-19 07:29AM	ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress PR Newswire
07:29AM	ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress CNW Group
Sep-23-19 02:52PM	Investor goes activist, buys $64 million in Acadia stock American City Business Journals
Sep-19-19 07:30AM	ESSA to Present at Ladenburg Thalmann Healthcare Conference PR Newswire +7.02%
07:30AM	ESSA to Present at Ladenburg Thalmann Healthcare Conference CNW Group
Aug-27-19 09:21AM	ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million CNW Group +6.04%
Aug-26-19 01:45PM	EPIX: Initiating Coverage of ESSA Pharma Inc.; Unique Mechanism Targeting the Androgen Receptor in Prostate Cancer Zacks Small Cap Research
Aug-24-19 01:46PM	10 Biopharmaceutical Companies Trying To Cure Cancer Benzinga
Aug-23-19 10:37AM	ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement PR Newswire +22.22%
10:37AM	ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement CNW Group
Aug-14-19 07:30AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019 PR Newswire
07:30AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019 CNW Group
Jul-31-19 04:45AM	ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective CNW Group -14.70%
Jul-30-19 02:15AM	ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics PR Newswire +5.65%
Jul-15-19 07:30AM	ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer CNW Group
Jul-08-19 03:39PM	ESSA Provides Update on Court Hearing PR Newswire -7.30%
03:39PM	ESSA Provides Update on Court Hearing CNW Group
Jun-26-19 06:08PM	ESSA Provides an Update to the Acquisition of Realm Therapeutics PR Newswire +6.87%
Jun-25-19 10:40PM	ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders PR Newswire
10:40PM	ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders CNW Group
Jun-21-19 08:30PM	ESSA Pharma to Hold Annual Shareholders' Meeting and Announces Three Realm-Nominated Directors CNW Group
May-22-19 09:00AM	What Makes ESSA Pharma (EPIX) a New Buy Stock Zacks -6.98%
May-20-19 11:35AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Realm Therapeutics plc to ESSA Pharma Inc., LLC is Fair to Shareholders GlobeNewswire
May-16-19 06:30AM	Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics PR Newswire
06:30AM	Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics CNW Group
May-10-19 07:30AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019 CNW Group -7.15%
May-04-19 04:00PM	Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting CNW Group
Apr-25-19 07:30AM	ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019 PR Newswire
07:30AM	ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019 CNW Group
Apr-17-19 07:30AM	ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting PR Newswire
07:30AM	ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting CNW Group
Apr-12-19 02:00AM	ESSA Pharma Grants Stock Options PR Newswire
02:00AM	ESSA Pharma Grants Stock Options CNW Group
Mar-28-19 05:02PM	ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019 PR Newswire
05:01PM	ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer PR Newswire
Mar-18-19 07:30AM	ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference CNW Group
Mar-14-19 07:30AM	ESSA Pharma to Attend the 31st Annual ROTH Conference PR Newswire
Feb-11-19 07:30AM	ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium PR Newswire
07:30AM	ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium CNW Group
Feb-07-19 05:05PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018 PR Newswire
Dec-13-18 05:02PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018 PR Newswire
Nov-14-18 07:35AM	Investor Expectations to Drive Momentum within Townsquare Media, Koss, ESSA Pharma, MVC Capital, Valeritas, and Sonic Foundry Discovering Underlying Factors of Influence GlobeNewswire
Oct-22-18 07:00AM	ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors PR Newswire
Aug-29-18 07:00AM	ESSA Pharma to Present at 20th Annual Global Investment Conference In New York City September 4 - 6, 2018 PR Newswire
Aug-14-18 07:00AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018 CNW Group
May-14-18 07:15PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018 CNW Group -5.16%
May-10-18 05:05PM	Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements CNW Group
Apr-26-18 07:00AM	ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018 CNW Group
Apr-25-18 07:00AM	ESSA Pharma Inc. Announces Completion of Share Consolidation CNW Group
Apr-24-18 07:30AM	ESSA Pharma Enhances R&D Capabilities with Two New Key Hires CNW Group +8.12%
Apr-19-18 07:38PM	ESSA Pharma Inc. Announces Share Consolidation CNW Group +5.69%
Apr-12-18 09:51AM	Does ESSA Pharma Inc (CVE:EPI) Go Up With The Market? Simply Wall St.
Mar-28-18 09:56PM	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
Feb-23-18 09:02AM	ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants PR Newswire
09:02AM	ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants CNW Group
Feb-13-18 05:00PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 PR Newswire
05:00PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 CNW Group
Jan-26-18 07:00AM	ESSA to Present at Noble Capital Markets' NobleCon14 PR Newswire
07:00AM	ESSA to Present at Noble Capital Markets' NobleCon14 CNW Group
Jan-25-18 11:00PM	ESSA Announces Management Team Change PR Newswire -6.33%
11:00PM	ESSA Announces Management Team Change CNW Group
Jan-16-18 09:40PM	ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule CNW Group
08:40AM	ESSA Completes Second Tranche of Equity Offering, Raising Additional US$5 Million PR Newswire
Jan-09-18 08:43AM	ESSA Completes US$21 Million Equity Offering PR Newswire -9.72%

ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience